tag:blogger.com,1999:blog-18523369.post1762578927242935481..comments2023-05-27T20:41:00.441+08:00Comments on The Second Sight: Still Not A Doctor, Still Providing Health AdviceEoRhttp://www.blogger.com/profile/08565450093920373243noreply@blogger.comBlogger4125tag:blogger.com,1999:blog-18523369.post-20005450273700324602010-09-27T18:23:27.283+08:002010-09-27T18:23:27.283+08:00hahahah sorry
*proper*hahahah sorry<br />*proper*Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-18523369.post-48762862632760532172010-09-27T17:32:52.167+08:002010-09-27T17:32:52.167+08:00So you've posted a list of references Dr Dingl...So you've posted a list of references Dr Dingle. You're about as qualified to interpret, analyse and debate them as I am, which is to say not at all.<br /><br />You may have some points, but I don't give them any credence because they're not based on research. If you have a serious interest in changing the dominant paradigm when it comes to health science, why don't you actually conduct your own research? You have a PhD: you might need to do further study in the issues you're interested in (which involve physiology, chemistry, anatomy, food science and so on) but you could proceed from there with your scientific training.<br />There are people out there challenging dominant views and the might of the pharmaceutical industry, and doing proper science, not writing garbled blog posts and paperback books with cartoons on the cover - for example Kirsch and his excellent work on the inefficacy of antidepressants at University of Hull. (also, I'm a nitpicky English graduate and I wonder how you think you can have any academic credibility when you write things like 'i am a scientist' and fail to use poper punctuation).<br /><br />Oh that's right. You can't make money selling books, appearing on radio and tv (well I think those days are probably gone) to sell your books, and speaking on topice you're totally not qualified in, if you're stuck in a lab chasing funding, designing and conducting studies, analysing data and writing up your results.<br />Far more lucrative, and much easier, to read stuff that other people have worked long and hard on, and make shit up.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-18523369.post-80581514242631148942010-09-23T09:16:15.871+08:002010-09-23T09:16:15.871+08:00please find the references included below
it would...please find the references included below<br />it would only allow me to post one chapters worth but i can provide many more if you require. i love what you are doing. this is really about time we had a public debate<br /> <br />Rosenberg, H. and D. Allard (2007). Evidence for Caution: Women and Statin Use. Winnipeg, Canadian Women’s Health Network.<br />"Narrative review: Lack of evidence for recommended low-density lipoprotein treatment targets: A solvable problem." Annals of Internal Medicine 145(7): 520-530.<br />University of British Columbia (2003). "Do statins have a role in primary prevention? A review by the Therapeutics Initiative of the Department of Pharmacology & Therapeutics of the University of British Columbia." Therapeutics Letter (48).<br />Fidan, D., B. Unal, et al. (2007). "Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000–2010." QJM 100: 277-289.<br />Franco, O.H., A. Peeters, et al. (2005). "Cost effectiveness of statins in coronary heart disease." Journal of Epidemiology and Community Health 59: 927-933.<br />Franco, O.H., E.W. Steyerberg, et al. (2006). "Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention." Journal of Epidemiology & Community Health 60: 839-845.<br />Capewell, S. (2008). "Will screening individuals at high risk of cardiovascular events deliver large benefits? No." British Medical Journal 337: a1395.<br />Nuovo, J., J. Melnikow, et al. (2002). "Reporting number needed to treat and absolute risk reduction in randomized controlled trials." Journal of American Medical Association 287: 2813-2814.<br />Miall, W.E. and G. Greenberg (1987). Mild Hypertension: Is There Pressure to Treat? An account of the MRC trial. New York, Cambridge University Press.<br />Shepherd, J., S.M. Cobbe, et al. (1996). "Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia." New England Journal of Medicine 333: 1301-1307.<br />Heart Protection Study Collaborative Group (2002). "MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial." Lancet 360: 7-22.<br />Ravnskov, U. (2002). "Statins as the new Aspirin. Conclusions from the heart protection study were premature." British Medical Journal 324: 789. <br />Ridker, P.M., E. Danielson, et al. (2008). "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein." New England Journal of Medicine 359(21): 2195-2207.<br />Ray, K.K., S.R.K. Seshasai, et al. (2010). "Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65 229 participants." Archives of Internal Medicine 170(12): 1024-1031.<br />de Lorgeril, M., P. Salen, et al. (2010). "Cholesterol lowering, cardiovascular diseases, and the Rosuvastatin-JUPITER controversy: A critical reappraisal." Archives of Internal Medicine 170(12): 1032-1036.<br />Brugts, J.J., T. Yetgin, et al. (2009). "The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials." British Medical Journal 338: b2376.<br />Franco, O.H., A. Peeters, et al. (2005). "Cost effectiveness of statins in coronary heart disease." Journal of Epidemiology and Community Health 59: 927-933.<br />Fidan, D., B. Unal, et al. (2007). "Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000–2010." QJM 100: 277-289.<br />Liao, J.K. (2002). "Isoprenoids as mediators of the biological effects of statins." Journal of Clinical Investigation 110(3): 285-288.<br />Holman, J.R. (2007) Some docs in denial about statin side effects. DOC News 4(12), 1-12.Dr Dhttps://www.blogger.com/profile/11967618986672911127noreply@blogger.comtag:blogger.com,1999:blog-18523369.post-50834512492985808232010-09-21T12:26:11.363+08:002010-09-21T12:26:11.363+08:00Shall we start the countdown to his appearance on ...Shall we start the countdown to his appearance on either Sunrise, Today Tonight or Sattler?<br /><br />Maybe we should spam his message around, but with an appropriate preamble and links to some recent news items.Andyhttps://www.blogger.com/profile/08026511553591079915noreply@blogger.com